Forian (FORA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Election of Stanley S. Trotman, Jr. and Kristiina Vuori, M.D., Ph.D. as Class I directors to serve until the 2028 annual meeting or until successors are elected and qualified.
Proposal to amend the 2020 Equity Incentive Plan, increasing authorized shares for issuance by 4,000,000.
Ratification of CBIZ CPAS P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2025.
Other business may be addressed as appropriate at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Directors up for election are nominated for three-year terms, expiring at the 2028 annual meeting.
Executive compensation and say-on-pay
Proposal to amend the equity incentive plan would increase the pool of shares available for executive and employee compensation.
Latest events from Forian
- Net loss widened on lower revenue and higher costs, with a pending acquisition at $2.17 per share.FORA
Q1 2026 - Revenue up 50% to $30.3M, net loss narrows, and management proposes buyout.FORA
Q4 2025 - Re-domiciliation from Delaware to Maryland approved by majority stockholder vote.FORA
EGM 2026 - Stockholders to vote on redomiciling to Maryland, enabling a take-private offer and strategic flexibility.FORA
Proxy Filing - Redomiciliation to Maryland is proposed to enable a take-private offer, with majority support assured.FORA
Proxy Filing - Annual meeting to vote on director elections, equity plan expansion, and auditor ratification.FORA
Proxy Filing - Q3 2024 revenue fell 12% to $4.7M; Kyber acquisition and sales momentum set up future growth.FORA
Q3 2024 - Q2 revenue fell 2% to $4.8M, net loss widened, and 2024 guidance was lowered.FORA
Q2 2024 - Q1 2025 revenue up 45% to $7.1M, with narrowed net loss and strong 2025 growth outlook.FORA
Q1 2025